Tempus AI, Inc. $TEM Shares Sold by SeaCrest Wealth Management LLC

Key Points

• SeaCrest Wealth Management LLC reduced its holdings in Tempus AI, Inc. by 43.6%, selling 4,841 shares, and now owns 6,259 shares valued at $398,000.
• Insider trading activity includes CEO Eric P. Lefkofsky selling 332,500 shares for approximately $24.6 million, while insiders have collectively sold 601,787 shares worth about $42.5 million over the past ninety days.
• Tempus AI reported a quarterly revenue of $314.64 million, significantly exceeding analyst estimates, and has a consensus rating of "Moderate Buy" with a target price of $70.17.

SeaCrest Wealth Management LLC decreased its position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 43.6% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 6,259 shares of the company's stock after selling 4,841 shares during the quarter. SeaCrest Wealth Management LLC's holdings in Tempus AI were worth $398,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Cherry Tree Wealth Management LLC acquired a new position in shares of Tempus AI during the 1st quarter worth approximately $31,000. University of Texas Texas AM Investment Management Co. bought a new stake in shares of Tempus AI during the 1st quarter valued at about $33,000. Continuum Advisory LLC bought a new position in shares of Tempus AI in the first quarter valued at approximately $39,000. Bartlett & CO. Wealth Management LLC lifted its stake in Tempus AI by 100.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock valued at $39,000 after purchasing an additional 400 shares during the last quarter. Finally, Nemes Rush Group LLC purchased a new stake in Tempus AI in the 1st quarter worth approximately $39,000. Hedge funds and other institutional investors own 24.22% of the company's stock.

Insiders Place Their Bets

In other Tempus AI news, CEO Eric P. Lefkofsky sold 332,500 shares of the firm's stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $74.10, for a total transaction of $24,638,250.00. Following the sale, the chief executive officer owned 9,207,533 shares in the company, valued at approximately $682,278,195.30. This trade represents a 3.49% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO James William Rogers sold 7,528 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $561,965.20. Following the transaction, the chief financial officer owned 138,473 shares of the company's stock, valued at $10,337,009.45. This represents a 5.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 601,787 shares of company stock valued at $42,492,268 over the last quarter. 26.27% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Guggenheim raised their target price on shares of Tempus AI from $65.00 to $75.00 and gave the company a "buy" rating in a research note on Monday, June 30th. Bank of America boosted their price objective on shares of Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a report on Wednesday, June 25th. Needham & Company LLC reissued a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a research report on Friday, August 8th. Morgan Stanley increased their price target on shares of Tempus AI from $65.00 to $68.00 and gave the company an "overweight" rating in a research note on Tuesday, August 12th. Finally, BTIG Research raised their price target on shares of Tempus AI from $75.00 to $85.00 and gave the stock a "buy" rating in a research report on Wednesday, August 20th. Seven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $70.17.

Tempus AI Trading Down 2.7%

Shares of Tempus AI stock traded down $2.37 on Monday, reaching $85.87. The stock had a trading volume of 20,972,634 shares, compared to its average volume of 8,144,343. Tempus AI, Inc. has a 1 year low of $31.36 and a 1 year high of $97.79. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. The business's 50 day moving average is $71.02 and its two-hundred day moving average is $61.08.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. The firm had revenue of $314.64 million for the quarter, compared to the consensus estimate of $296.84 million. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The company's revenue for the quarter was up 89.5% on a year-over-year basis. During the same period in the prior year, the firm posted ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. Equities analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current year.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.